AAAAAA

   
Results: 1-16 |
Results: 16
HIGHER CEREBROSPINAL-FLUID MHPG IN SUBJECTS WITH DEMENTIA OF THE ALZHEIMER-TYPE - RELATIONSHIP WITH COGNITIVE DYSFUNCTION
Authors: SHELINE YI MILLER K BARDGETT ME CSERNANSKY JG
Citation: Yi. Sheline et al., HIGHER CEREBROSPINAL-FLUID MHPG IN SUBJECTS WITH DEMENTIA OF THE ALZHEIMER-TYPE - RELATIONSHIP WITH COGNITIVE DYSFUNCTION, The American journal of geriatric psychiatry, 6(2), 1998, pp. 155-161
AMYGDALA CORE NUCLEI VOLUMES ARE DECREASED IN RECURRENT MAJOR DEPRESSION
Authors: SHELINE YI GADO MH PRICE JL
Citation: Yi. Sheline et al., AMYGDALA CORE NUCLEI VOLUMES ARE DECREASED IN RECURRENT MAJOR DEPRESSION, NeuroReport, 9(9), 1998, pp. 2023-2028
IMPULSIVE AGGRESSION IN PERSONALITY-DISORDER CORRELATES WITH PLATELET5-HT2A RECEPTOR-BINDING
Authors: COCCARO EF KAVOUSSI RJ SHELINE YI BERMAN ME CSERNANSKY JG
Citation: Ef. Coccaro et al., IMPULSIVE AGGRESSION IN PERSONALITY-DISORDER CORRELATES WITH PLATELET5-HT2A RECEPTOR-BINDING, Neuropsychopharmacology, 16(3), 1997, pp. 211-216
CORRELATED REDUCTIONS IN CEREBROSPINAL-FLUID 5-HIAA AND MHPG CONCENTRATIONS AFTER TREATMENT WITH SELECTIVE SEROTONIN REUPTAKE INHIBITORS
Authors: SHELINE YI BARDGETT ME CSERNANSKY JG
Citation: Yi. Sheline et al., CORRELATED REDUCTIONS IN CEREBROSPINAL-FLUID 5-HIAA AND MHPG CONCENTRATIONS AFTER TREATMENT WITH SELECTIVE SEROTONIN REUPTAKE INHIBITORS, Journal of clinical psychopharmacology, 17(1), 1997, pp. 11-14
PERSONALITY-DISORDER SCORES IMPROVE WITH EFFECTIVE PHARMACOTHERAPY OFDEPRESSION
Authors: BLACK KJ SHELINE YI
Citation: Kj. Black et Yi. Sheline, PERSONALITY-DISORDER SCORES IMPROVE WITH EFFECTIVE PHARMACOTHERAPY OFDEPRESSION, Journal of affective disorders, 43(1), 1997, pp. 11-18
DEPRESSION AND CORONARY HEART-DISEASE - A REVIEW FOR CARDIOLOGISTS
Authors: CARNEY RM FREEDLAND KE SHELINE YI WEISS ES
Citation: Rm. Carney et al., DEPRESSION AND CORONARY HEART-DISEASE - A REVIEW FOR CARDIOLOGISTS, Clinical cardiology, 20(3), 1997, pp. 196-200
HOW SAFE ARE SEROTONIN REUPTAKE INHIBITORS FOR DEPRESSION IN PATIENTSWITH CORONARY HEART-DISEASE
Authors: SHELINE YI FREEDLAND KE CARNEY RM
Citation: Yi. Sheline et al., HOW SAFE ARE SEROTONIN REUPTAKE INHIBITORS FOR DEPRESSION IN PATIENTSWITH CORONARY HEART-DISEASE, The American journal of medicine, 102(1), 1997, pp. 54-59
HIPPOCAMPAL ATROPHY IN MAJOR DEPRESSION - A RESULT OF DEPRESSION-INDUCED NEUROTOXICITY
Authors: SHELINE YI
Citation: Yi. Sheline, HIPPOCAMPAL ATROPHY IN MAJOR DEPRESSION - A RESULT OF DEPRESSION-INDUCED NEUROTOXICITY, Molecular psychiatry, 1(4), 1996, pp. 298-299
STEREOLOGICAL MRI VOLUMETRY OF THE FRONTAL-LOBE
Authors: SHELINE YI BLACK KJ LIN DY CHRISTENSEN GE GADO MH BRUNSDEN BS VANNIER MW
Citation: Yi. Sheline et al., STEREOLOGICAL MRI VOLUMETRY OF THE FRONTAL-LOBE, PSYCHIATRY RESEARCH-NEUROIMAGING, 67(3), 1996, pp. 203-214
CSF 5-HIAA AND MHPG ARE DECREASED AND CORRELATED AFTER SELECTIVE SEROTONIN REUPTAKE INHIBITOR (SSRI) TREATMENT
Authors: SHELINE YI BARDGETT ME CSERNANSKY JG
Citation: Yi. Sheline et al., CSF 5-HIAA AND MHPG ARE DECREASED AND CORRELATED AFTER SELECTIVE SEROTONIN REUPTAKE INHIBITOR (SSRI) TREATMENT, Psychopharmacology bulletin, 32(3), 1996, pp. 512-512
CSF EXCITATORY AMINO-ACIDS AND SEVERITY OF ILLNESS IN ALZHEIMERS-DISEASE
Authors: CSERNANSKY JG BARDGETT ME SHELINE YI MORRIS JC OLNEY JW
Citation: Jg. Csernansky et al., CSF EXCITATORY AMINO-ACIDS AND SEVERITY OF ILLNESS IN ALZHEIMERS-DISEASE, Neurology, 46(6), 1996, pp. 1715-1720
HIPPOCAMPAL ATROPHY IN RECURRENT MAJOR DEPRESSION
Authors: SHELINE YI WANG PW GADO MH CSERNANSKY JG VANNIER MW
Citation: Yi. Sheline et al., HIPPOCAMPAL ATROPHY IN RECURRENT MAJOR DEPRESSION, Proceedings of the National Academy of Sciences of the United Statesof America, 93(9), 1996, pp. 3908-3913
PLATELET BINDING CHARACTERISTICS DISTINGUISH PLACEBO RESPONDERS FROM NONRESPONDERS IN DEPRESSION
Authors: SHELINE YI BLACK KJ BARDGETT ME CSERNANSKY JG
Citation: Yi. Sheline et al., PLATELET BINDING CHARACTERISTICS DISTINGUISH PLACEBO RESPONDERS FROM NONRESPONDERS IN DEPRESSION, Neuropsychopharmacology, 12(4), 1995, pp. 315-322
PLATELET PAROXETINE BINDING IN MAJOR DEPRESSIVE DISORDER WITH AND WITHOUT COMORBID OBSESSIVE-COMPULSIVE DISORDER
Authors: NELSON EC SHELINE YI BARDGETT ME JACKSON JL CSERNANSKY JG
Citation: Ec. Nelson et al., PLATELET PAROXETINE BINDING IN MAJOR DEPRESSIVE DISORDER WITH AND WITHOUT COMORBID OBSESSIVE-COMPULSIVE DISORDER, Psychiatry research, 58(2), 1995, pp. 117-125
PAROXETINE AS MIGRAINE PROPHYLAXIS
Authors: BLACK KJ SHELINE YI
Citation: Kj. Black et Yi. Sheline, PAROXETINE AS MIGRAINE PROPHYLAXIS, The Journal of clinical psychiatry, 56(7), 1995, pp. 330-331
PLATELET SEROTONIN MARKERS AND DEPRESSIVE SYMPTOMATOLOGY
Authors: SHELINE YI BARDGETT ME JACKSON JL NEWCOMER JW CSERNANSKY JG
Citation: Yi. Sheline et al., PLATELET SEROTONIN MARKERS AND DEPRESSIVE SYMPTOMATOLOGY, Biological psychiatry, 37(7), 1995, pp. 442-447
Risultati: 1-16 |